The Institute of Pharmaceutical Biotechnology


At our institute we combine structural biology (mainly X-ray crystallogrpahy), biophysical approaches, and biochemistry with cell biology to allow for an integrated research approach.

Research topics focus on RNA-based gene regulation in eukaryotes (Niessing), structure-guided inhibitor design (Niessing), and various areas of biotechnology, including biomaterials for medical applications and recombinant biosurfactants for a growing bioeconomy (Rosenau). For more details, please visit the groups subpages under the RESEARCH pulldown menue.



Recent Publications

Horlamus F, Wittgens A, Noll P, Michler J, Müller I, Weggenmann F, Oellig C, Rosenau F, Henkel M, Hausmann R .
One‐step bioconversion of hemicellulose polymers to rhamnolipids with Cellvibrio japonicus: A proof‐of‐concept for a potential host strain in future bioeconomy.
Global Change Biology (GCB) Bioenergy. (2018)

Wittgens A, Rosenau F. On the road towards tailor-made rhamnolipids: current state and perspectives.
Appl Microbiol Biotechnol. (2018)

Bodenberger, N. et al. Lectin-Functionalized Composite Hydrogels for "Capture-and-Killing" of Carbapenem-Resistant Pseudomonas aeruginosa. Biomacromolecules (2018)

Rehage, N. et al. Binding of NUFIP2 to Roquin promotes recognition  and regulation of ICOS mRNA.
Nat. Commun
. ( 2018)

Edelmann, F. et al. Molecular architecture and dynamics of ASH1 mRNA recognition by its mRNA-transport complex.
Nat. Struct. Mol. Biol.

Weber, J. et al. Structural basis of nucleic-acid recognition and double-strand unwinding by the essential neuronal protein Pur-alpha.

The DFG Research Unit FOR2333 " consists of seven German-wide teams (speaker: Ulm University).


The DFG Priority Program SPP1935 aims at understanding RNA-bound determinants of posttranscriptional gene regulation.